Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Design of a Medical Device for Oxaliplatin-Induced Peripheral Neuropathy Considering the Patient's Voice in Gastrointestinal Cancer

NCT06873360 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.

NCT NCT06873360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06873360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Design of a Medical Device for Oxaliplatin-Induced Peripheral Neuropathy Considering the Patient's Voice in Gastrointestinal Cancer
Lead sponsor
Corporacion Parc Tauli
Phase
Observational
Overall status
Completed
Start date
April 1, 2025
Completion date
December 30, 2025
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral neuropathy due to chemotherapy